Anebulo Pharmaceuticals Ownership | Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals Ownership Summary

Anebulo Pharmaceuticals is owned by 1.07% institutional investors, 40.84% insiders, and 58.10% retail investors. Vanguard group is the largest institutional shareholder, holding 1.06% of ANEB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.61% of its assets in Anebulo Pharmaceuticals shares.

ANEB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Anebulo Pharmaceuticals	1.07%	40.84%	58.10%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	435.82K	1.06%	$440.18K
Xtx topco	19.15K	0.06%	$47.88K
Boothbay fund management	18.84K	0.06%	$47.09K
Blackrock	3.76K	0.01%	$10.27K
Bank of america corp /de/	65.00	0.00%	$177.00
Susquehanna group, llp	-	-	-
Barclays	-	-	-
Tower research capital llc (trc)	-	-	-
Lvw advisors	-	-	-
22nw, lp	-	-	-

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Xtx topco	19.15K	0.00%	$47.88K
Boothbay fund management	18.84K	0.00%	$47.09K
Blackrock	3.76K	-	$10.27K
Tower research capital llc (trc)	-	-	-
Barclays	-	-	-
Susquehanna group, llp	-	-	-
Lvw advisors	-	-	-
Bank of america corp /de/	65.00	-	$177.00
22nw, lp	-	-	-
Renaissance	-	-	-

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	435.82K	-	129.28K
Xtx topco	19.15K	0.00%	19.15K
Bank of america corp /de/	65.00	-	65.00
Boothbay fund management	18.84K	0.00%	-
Citigroup	-	-	-6.00

Top Sellers

Holder	Shares	% Assets	Change
22nw, lp	-	-	-15.47M
Nantahala capital management	-	-	-3.04M
Mangrove partners	-	-	-2.53M
Morgan stanley	-	-	-399.40K
Lvw advisors	-	-	-349.62K

New Positions

Holder	Shares	% Assets	Change	Value
Xtx topco	19.15K	0.00%	19.15K	$47.88K

Sold Out

Holder	Change
Citigroup	-6.00
Ameritas advisory services	-10.00
Wells fargo & company/mn	-62.00
Barclays	-399.00
Pnc financial services group	-1.53K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	2	-90.00%	438,155	-98.03%	1	0.02%	2	-83.33%	-	-100.00%
Sep 30, 2025	3	-80.00%	308,684	-98.61%	-	0.01%	3	-57.14%	-	-100.00%
Jun 30, 2025	18	-	22,591,946	-0.12%	82	2.72%	8	-11.11%	3	-25.00%
Mar 31, 2025	18	20.00%	22,618,242	0.21%	55	0.73%	9	12.50%	4	-
Dec 31, 2024	15	15.38%	22,570,347	207.34%	87	10.85%	8	60.00%	4	33.33%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	248.95K	0.61%	-8.96K
Vanguard US Total Market Shares ETF	121.00K	0.29%	-
Vanguard Institutional Extnd Mkt Idx Tr	116.25K	0.28%	-
Fidelity Extended Market Index	47.52K	0.12%	-
Fidelity Total Market Index	46.01K	0.11%	-
Fidelity Series Total Market Index	20.61K	0.05%	-
iShares Micro-Cap ETF	20.17K	0.05%	-
Spartan Total Market Index Pool G	19.41K	0.05%	-
NT Ext Equity Mkt Idx Fd - NL	15.06K	0.04%	15.06K
Spartan Extended Market Index Pool F	13.81K	0.03%	-

Recent Insider Transactions

Date	Name	Activity	Value
Dec 23, 2024	English Aron R.	Buy	$10.00M
Dec 17, 2021	English Aron R.	Buy	$2.63K
Dec 14, 2021	English Aron R.	Buy	$2.43K
Dec 03, 2021	English Aron R.	Buy	$26.68K
Dec 02, 2021	English Aron R.	Buy	$73.33K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	-	-
2023 Q3	-	-

ANEB Ownership FAQ

Who Owns Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals shareholders are primarily institutional investors at 1.07%, followed by 40.84% insiders and 58.09% retail investors. The average institutional ownership in Anebulo Pharmaceuticals's industry, Biotech Stocks , is 35.75%, which Anebulo Pharmaceuticals falls below.

Who owns the most shares of Anebulo Pharmaceuticals?

Anebulo Pharmaceuticals’s largest shareholders are Vanguard group (435.82K shares, 1.06%), Xtx topco (19.15K shares, 0.06%), and Boothbay fund management (18.84K shares, 0.06%). Together, they hold 1.17% of Anebulo Pharmaceuticals’s total shares outstanding.

Does Blackrock own Anebulo Pharmaceuticals?

Yes, BlackRock owns 0.01% of Anebulo Pharmaceuticals, totaling 3.76K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 10.27K$. In the last quarter, BlackRock decreased its holdings by -288 shares, a -7.11% change.

Who is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Xtx topco is Anebulo Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.00% of its assets in 19.15K Anebulo Pharmaceuticals shares, valued at 47.88K$.

Who is the top mutual fund holder of Anebulo Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Anebulo Pharmaceuticals shares, with 0.61% of its total shares outstanding invested in 248.95K Anebulo Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools